Cargando…
Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson’s disease primate model
Metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) to the neurotoxin MPP(+) in the brain causes permanent Parkinson’s disease-like symptoms by destroying dopaminergic neurons in the pars compacta of the substantia nigra in humans and non-human primates. However, the complete molecular...
Autores principales: | Kaya, Ibrahim, Nilsson, Anna, Luptáková, Dominika, He, Yachao, Vallianatou, Theodosia, Bjärterot, Patrik, Svenningsson, Per, Bezard, Erwan, Andrén, Per E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372136/ https://www.ncbi.nlm.nih.gov/pubmed/37495571 http://dx.doi.org/10.1038/s41531-023-00558-1 |
Ejemplares similares
-
Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood–brain barrier
por: Luptáková, Dominika, et al.
Publicado: (2021) -
Basal ganglia neuropeptides show abnormal processing associated with L-DOPA-induced dyskinesia
por: Hulme, Heather, et al.
Publicado: (2022) -
Molecular imaging identifies age-related attenuation of acetylcholine in retrosplenial cortex in response to acetylcholinesterase inhibition
por: Vallianatou, Theodosia, et al.
Publicado: (2019) -
Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA–induced dyskinesia
por: Fridjonsdottir, Elva, et al.
Publicado: (2021) -
Cross-validated Matrix-Assisted Laser Desorption/Ionization
Mass Spectrometry Imaging Quantitation Protocol for a Pharmaceutical
Drug and Its Drug-Target Effects in the Brain Using Time-of-Flight
and Fourier Transform Ion Cyclotron Resonance Analyzers
por: Källback, Patrik, et al.
Publicado: (2020)